| http://www.w3.org/ns/prov#value | - This study, which used a retrospective analysis of insurance claims data, showed that some of the benefits seen in the full study population also applied to younger children; in children aged 1 to 2 yrs, the risk of respiratory illness other than pneumonia was 37% lower in those who received oseltamivir than in those using no antiviral treatment, and in those aged 3 to 5 yrs, the risk of otitis me
|
